K Number
K202063
Device Name
TrusFIL Universal Composite Restorative
Date Cleared
2021-10-06

(436 days)

Product Code
Regulation Number
872.3690
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
TrusFIL Universal Composite Restorative is a visible light curing dental restorative material indicated for: - Direct anterior and posterior restorations (including occlusal surfaces); - Core Build-ups; - Splinting: - Indirect restorations including inlays, onlays and veneers.
Device Description
TrusFIL Universal Composite Restorative is a visible-light activated, restorative composite designed for use in anterior and posterior restorations. The principal organic components are mixtures of dental methacrylate resins (Bis-GMA, EBPADMA). The inorganic filler loading is about 54% by volume having particle size range of about 0.01 to 2 microns. It is packaged in syringes and single-dose capsules. Single-dose delivery is intended for single patient (single use) only to prevent cross-contamination between patients. Available shades include opaque dentin shades, regular body shades and enamel shades. All shades are radiopaque.
More Information

No reference devices were used in this submission.

No
The device description and intended use are for a dental composite material, and there is no mention of AI or ML in the provided text.

No
This device is a dental restorative material used to fill cavities and build up tooth structure, not to treat or cure a disease.

No
Explanation: This device is a dental restorative material, meaning it is used for filling cavities and building up tooth structure, not for diagnosing conditions.

No

The device is a physical dental restorative material, not a software application.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use clearly states it's a "dental restorative material" for direct and indirect restorations, core build-ups, and splinting. These are all procedures performed on the patient's teeth, not tests performed on samples taken from the patient.
  • Device Description: The description details the composition of the material (resins, fillers) and its packaging (syringes, capsules). This aligns with a material used in dental procedures, not a diagnostic test kit or instrument.
  • Lack of Diagnostic Elements: There is no mention of analyzing biological samples (blood, urine, tissue, etc.), detecting biomarkers, or providing diagnostic information about a patient's health condition.
  • Anatomical Site: The anatomical site is "Anterior and posterior teeth," which is where the material is applied, not where a sample is taken from.

IVD devices are used to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. This device is a material used to repair or restore teeth, which is a therapeutic or restorative function, not a diagnostic one.

N/A

Intended Use / Indications for Use

TrusFIL Universal Composite Restorative is a visible light curing dental restorative material indicated for:

  • Direct anterior and posterior restorations (including occlusal surfaces);
  • Core Build-ups;
  • Splinting;
  • Indirect restorations including inlays, onlays and veneers.

Product codes

EBF

Device Description

TrusFIL Universal Composite Restorative is a visible-light activated, restorative composite designed for use in anterior and posterior restorations. The principal organic components are mixtures of dental methacrylate resins (Bis-GMA, EBPADMA). The inorganic filler loading is about 54% by volume having particle size range of about 0.01 to 2 microns. It is packaged in syringes and single-dose capsules. Single-dose delivery is intended for single patient (single use) only to prevent cross-contamination between patients. Available shades include opaque dentin shades, regular body shades and enamel shades. All shades are radiopaque.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies

In-vitro bench tests were performed on the TrusFIL Universal Composite Restorative including the items listed in the table 4 below. The test results indicated that the TrusFIL Universal Composite Restorative meets the pass/fail criteria and supports substantial equivalence when compared to the predicate device on physical properties.

Key Metrics

Not Found

Predicate Device(s)

K083610

Reference Device(s)

No reference devices were used in this submission.

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 872.3690 Tooth shade resin material.

(a)
Identification. Tooth shade resin material is a device composed of materials such as bisphenol-A glycidyl methacrylate (Bis-GMA) intended to restore carious lesions or structural defects in teeth.(b)
Classification. Class II.

0

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, with the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG" in large, bold, blue letters, and the word "ADMINISTRATION" in smaller, blue letters below.

October 6, 2021

Rizhao HuGe Biomaterials Company, Ltd. Maggie Zheng Regulatory Affairs Manager No.2 North Zhaoyang Road, District of Donggang Rizhao City, Shandong Province 276800 CHINA

Re: K202063/S002

Trade/Device Name: TrusFIL Universal Composite Restorative Regulation Number: 21 CFR 872.3690 Regulation Name: Tooth Shade Resin Material Regulatory Class: Class II Product Code: EBF Dated: July 28, 2021 Received: August 9, 2021

Dear Maggie Zheng:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

1

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely.

Michael E. Adjodha, M.ChE. Assistant Director DHT1B: Division of Dental and ENT Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

2

Indications for Use

510(k) Number (if known) K202063

Device Name

TrusFIL Universal Composite Restorative

Indications for Use (Describe)

TrusFIL Universal Composite Restorative is a visible light curing dental restorative material indicated for:

  • Direct anterior and posterior restorations (including occlusal surfaces);

  • Core Build-ups:

  • Splinting;

  • Indirect restorations including inlays, onlays and veneers.

Type of Use (Select one or both, as applicable)

Prescription Use (Part 21 CFR 801 Subpart D)

_ Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

3

510 (k) Summary-K202063

This summary of 510(k) for the subjective device equivalence information is being submitted in accordance with the requirements of 21 C.F.R. 807.92.

  • Date Summary Prepared: September 29, 2021 1.

2. Submitter Information:

Owner's NameRizhao HuGe Biomaterials Company, Ltd.
AddressNo.2 North Zhaoyang Road, District of Donggang, Rizhao City,
Shandong Province, China 276800
Telephone0086 633 2277268
Fax0086 633 2277298
Contact PersonMrs. Maggie Zheng
Contact TitleRegulatory Affairs Manager
E-mailzhengxy@hugedent.com

3. Device Name

Trade name: TrusFIL Universal Composite Restorative

Common name: Universal Composite Restorative

Classification name: Material, Tooth Shade, Resin

Regulatory Class: II

Product Code: EBF

Predicate Device Information 4.

Table 1: Predicate Device Information
Owner/OperatorDevice Trade Name510 (k) No.Product CodePredicate
3M ESPE Dental ProductsFiltek Supreme Ultra Universal
RestorativeK083610EBFPrimary

This predicate device has not been subject to a design-related recall.

4

510 (k) Summarv-K202063

No reference devices were used in this submission.

5. Description of Device

TrusFIL Universal Composite Restorative is a visible-light activated, restorative composite designed for use in anterior and posterior restorations. The principal organic components are mixtures of dental methacrylate resins (Bis-GMA, EBPADMA). The inorganic filler loading is about 54% by volume having particle size range of about 0.01 to 2 microns. It is packaged in syringes and single-dose capsules. Single-dose delivery is intended for single patient (single use) only to prevent cross-contamination between patients.

Available shades include opaque dentin shades, regular body shades and enamel shades. All shades are radiopaque.

6. Indications for Use

TrusFIL Universal Composite Restorative is a visible light curing dental restorative material indicated for:

  • Direct anterior and posterior restorations (including occlusal surfaces);
  • Core Build-ups;
  • Splinting:
  • Indirect restorations including inlays, onlays and veneers.

7. Summary of Physical Properties Tests

TrusFIL Universal Composite Restorative is classified as Type 1 Class 2 and both Group 1 and Group 2 in accordance with ISO 4049: 2009. The physical properties were determined and tested according to ISO 4049: 2009 and FDA guidance "Guidance for Industry and FDA Staff Dental Composite Resin Devices -Premarket Notification [510(k)|Submissions Document issued on: October 26, 2005".

In-vitro bench tests were performed on the TrusFIL Universal Composite Restorative including the items listed in the table 4 below. The test results indicated that the TrusFIL Universal Composite Restorative meets the pass/fail criteria and supports substantial equivalence when compared to the predicate device on physical properties.

5

HUGE 510 (k) Summary-K202063

Table 4: Summary of Physical Properties Test
ItemsPass/fail criteriaConclusion
ISO 4049: 2009
5.2.7 Sensitivity to ambient light,
Class 2 materialsThe material shall remain physically
homogeneous.Meet the criteria
per ISO 4049
ISO 4049: 2009
5.2.8 Depth of cure, Class 2 materialsOpaque restorative materials: ≥1 mm
Other restorative materials: ≥1.5 mmMeet the criteria
per ISO 4049
ISO 4049: 2009
5.2.9 Flexural strengthThe flexural strength shall be equal to or greater
than 100 MPa.Meet the criteria
per ISO 4049
ISO 4049: 2009
5.2.10 Water sorption and solubilitya) The water sorption shall be ≤ 40 µg/mm3.
b) The solubility shall be shall be ≤ 7.5 µg/mm3.Meet the criteria
per ISO 4049
ISO 4049: 2009
5.3 Shade, restorative materialsThe shade of the set material shall match closely
that of the manufacturer's shade guide. The set
material shall be evenly pigmented when viewed
without magnification.Meet the criteria
per ISO 4049
ISO 4049: 2009
5.4 Colour stability after irradiation
and water sorptionNo more than a slight change in colour shall be
observed.Meet the criteria
per ISO 4049
ISO 4049: 2009
5.5 Radio-opacityThe radio-opacity shall be equal to or greater than
that of the same thickness of aluminium (1 mm of
material).Meet the criteria
per ISO 4049
FDA guidance
Elastic modulusThe elastic modulus shall be equal to or greater
than 2 GPa.Meet the criteria
per internal
standard
FDA guidance
Surface hardnessThe surface hardness shall be equal to or greater
than 30HV.Meet the criteria
per internal
standard
FDA guidance
Compressive strengthThe compressive strength shall be equal to or
greater than 200 MPa.Meet the criteria
per internal
standard

8. Technological Characteristics

6

HUGE 510 (k) Summary-K202063

The following table shows the significant technological characteristics and indicates the similarities and differences with the predicate device:

Table 5: Technological Characteristics Comparison Table
Technological
CharacteristicsSubject devicePrimary predicate device
TrusFIL Universal Composite Restorative
(K202063)Filtek Supreme Ultra Universal
Restorative(K083610)
Composition
of MaterialsMethacrylate-based resins, photo initiator,
fillers and pigments.Methacrylate-based resins, photo initiator,
fillers and pigments.
Physical FormPastePaste
Indications of UseTrusFILUniversal Composite Restorative
is a visible light curing dental restorative
material indicated for:
  • Direct anterior and posterior restorations
    (including occlusal surfaces);
  • Core Build-ups;
  • Splinting;
  • Indirect restorations including inlays,
    onlays and veneers. | Filtek Supreme Ultra universal restorative is
    indicated for use in:
    • Direct anterior and posterior restorations
    (including occlusal surfaces)
    • Core Build-ups
    • Splinting
    • Indirect restorations including inlays,
    onlays and veneers |
    | Prescription/over-
    the-counter use | Prescription | Prescription |
    | Curing method | Light cure | Light cure |
    | Delivery form | Syringe and single-dose capsule | Syringe and single-dose capsule |
    | Radio-opacity | Meet the criteria per ISO 4049 | Meet the criteria per ISO 4049 |
    | Physical Properties | The subject device and the predicate device have substantially equivalent physical
    properties as they all meet the criteria per ISO 4049 and conform to FDA guidance
    "Guidance for Industry and FDA Staff Dental Composite Resin Devices -Premarket
    Notification [510(k)]Submissions Document issued on: October 26, 2005". | |
    | FDA-Recognized
    Standards | ISO 4049; ISO 7405; ISO 10993-1 | ISO 4049; ISO 7405; ISO 10993-1 |

All compositions of the subject device are based upon industry well-known chemistry. The technological characteristics of the subject device are very similar to those of the predicate device, Filtek Supreme Ultra Universal Restorative (K083610). The subject device is a similar product, manufactured with similar materials and used in the same way by the same types of users and patient populations. The subject device and primary predicate device have minor

7

510 (k) Summary-K202063

different Indications for Use language in the first indication. However, the difference does not change the intended use or substantial equivalence, both products are intended for direct anterior and posterior restorations. Besides, other comparison items such as description of material, physical form, curing method, delivery form and physical properties, etc. are the same or very similar. And both products are supplied for prescription use.

9. Summary of Biocompatibility

The subject device, TrusFIL Universal Composite Restorative, is substantially equivalent to the predicate device that have been legally marketed for decades and with no clinical adverse events. The formulation of the subject device does not contain any non-conventional chemicals compared to the legally marketed predicate device.

Biocompatibility evaluation and tests were performed according to ISO 10993-1, ISO 7405 and FDA guidance "Use of International Standard ISO 10993-1, `Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process Document issued on: September 4, 2020". Biocompatibility tests include Cytotoxicity, Sensitization, Systemic Toxicity, Subchronic Toxicity, Genotoxicity and Pulp and Dentine Usage. TrusFIL Universal Composite Restorative has been demonstrated as biocompatible for its intended use.

10. Clinical Performance Data

Not applicable. Clinical performance testing has not been performed for the subject device.

11. Risk Analysis

The risk analysis of TrusFIL Universal Composite Restorative was conducted according to ISO 14971. As analyzed, the residual risk of the TrusFIL Universal Composite Restorative is considered acceptable. The benefits of the product are considered to outweigh the risks outlined in the risk analysis.

12. Conclusions

Based on the indications for use, technological characteristics, performance testing and comparison to predicate device, the subject device has been shown to be safe and effective for its intended use and the minor differences in indications for use fall within the intended use of

8

HUGE 510 (k) Summary-K202063

the predicate device affecting neither the general intended use nor substantial equivalence. Rizhao HuGe Biomaterials Company, Ltd. concludes that the subject device is substantially equivalent to the predicate device described herein.

13. Photo of the device

Image /page/8/Picture/3 description: The image shows a dental composite restorative product called TrusFil. The product comes in a syringe and a box. The box is beige with orange accents and contains the product name and description. The syringe is black and has a plunger on one end and a nozzle on the other. The syringe is labeled with the product name, weight (4g), and shade (A2).